Integrated Filing-Governance



General information about company

Scrip Code 543220
NSE Symbol MAXHEALTH
MSEI Symbol NOTLISTED
ISIN INE027H01010
Name of the entity MAX HEALTHCARE INSTITUTE LIMITED
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Reporting Quarter Quarterly
Date of Quarter Ending 31-Dec-2024
Type of company Equity
Whether Annexure I (Part A) of the SEBI Circular dated December 31, 2024 related to Compliance Report on Corporate Governance is applicable to the entity? Yes
Whether Annexure I (Part B) of the SEBI Circular dated December 31, 2024 related to Investor Grievance Redressal Report is Applicable to the entity? Yes
Whether Annexure I (Part C) of the SEBI Circular dated December 31, 2024 related to Disclosure of Acquisition of Shares or Voting Rights in Unlisted Companies is Applicable to the entity? Yes
Whether Annexure I (Part D) of the SEBI Circular dated December 31, 2024 related to Disclosure of Imposition of Fine or Penalty is Applicable to the entity? No
Reason For Part D Of Annexure I Disclosure Of Imposition Of Fine Or Penalty Is Not Applicable To The Entity No case reported for the quarter ending December 31, 2024.
Whether Annexure I (Part E) of the SEBI Circular dated December 31, 2024 related to Disclosure of Updates to Ongoing Tax Litigations or Disputes is Applicable to the entity? No
Reason For Part E Of Annexure I Disclosure Of Updates To Ongoing Tax Litigations Or Disputes Is Not Applicable To The Entity Tax litigation outcomes that may have an impact on the Company (i.e., material) and are required to be reported are NIL, as no tax disputes exceeding the material threshold limit are pending before any tax authority/ appellate authority/ court.
Risk management committee Yes
Market Capitalisation as per immediate previous Financial Year Top 500 listed entities
Is SCORE ID Available ? Yes
SCORE Registration ID COMZ00780
Reason For No SCORE ID
Type of Submission Original
Remarks (website dissemination)



Annexure I
Annexure I to be submitted by listed entity on quarterly basis
I. Composition of Board of Directors
Disclosure of notes on composition of board of directors explanatory Mr. Abhay Soi, Chairman and Managing Director is also promoter of the Company. Hence category Chairperson related to Promoter has been selected for him.
Whether the listed entity has a Regular Chairperson Yes
Whether Chairperson is related to MD or CEO Yes Disqualification of Directors under section 164 of the Companies Act, 2013
Sr Title (Mr / Ms) Name of the Director PAN DIN Category 1 of directors Category 2 of directors Category 3 of directors Date of Birth Whether the director is disqualified? Start Date of disqualification End Date of disqualification Details of disqualification Current status Whether special resolution passed? [Refer Reg. 17(1A) of Listing Regulations] Date of passing special resolution Initial Date of appointment Date of Re-appointment Date of cessation Tenure of director (in months) No of Directorship in listed entities including this listed entity (Refer Regulation 17A of Listing Regulations) No of Independent Directorship in listed entities including this listed entity [with reference to proviso to regulation 17A(1) & 17A(2)] Number of memberships in Audit/ Stakeholder Committee(s) including this listed entity (Refer Regulation 26(1) of Listing Regulations) No of post of Chairperson in Audit/ Stakeholder Committee held in listed entities including this listed entity (Refer Regulation 26(1) of Listing Regulations) Reason for Cessation Notes for not providing PAN Notes for not providing DIN
1 Mr. Abhay Soi 00203597 Executive Director Chairperson related to Promoter MD 19-Aug-1973 No Active NA 21-Jun-2019 19-Jun-2023 1 0 1 0
2 Ms. Amrita Gangotra 08333492 Non-Executive - Independent Director Not Applicable 03-Aug-1965 No Active NA 23-Aug-2023 23-Aug-2023 16.09 4 4 6 3
3 Mr. Anil Kumar Bhatnagar 09716726 Non-Executive - Non Independent Director Not Applicable 15-Aug-1950 No Active NA 31-Aug-2022 31-Aug-2022 1 0 0 0
4 Mr. Mahendra Gumanmalji Lodha 00012920 Non-Executive - Independent Director Not Applicable 04-Aug-1956 No Active NA 21-Jun-2019 21-Jun-2024 66.1 1 1 3 2
5 Mr. Michael Thomas Neeb 08522685 Non-Executive - Independent Director Not Applicable 19-Aug-1962 No Active NA 21-Jun-2019 21-Jun-2024 66.1 1 1 1 0 Textual Information(1)
6 Mr. Narayan Keelveedhi Seshadri 00053563 Non-Executive - Non Independent Director Not Applicable 13-Apr-1957 No Active NA 16-May-2023 16-May-2023 4 2 7 4
7 Mr. Pranav Chirayu Amin 00245099 Non-Executive - Independent Director Not Applicable 05-Oct-1975 No Active NA 10-Aug-2022 10-Aug-2022 28.22 3 2 2 1
8 Mr. Mehta Pranav Chandrakant 10738300 Non-Executive - Independent Director Not Applicable 16-Nov-1968 No Active NA 26-Aug-2024 26-Aug-2024 4.06 1 1 1 0



Text Block
Textual Information(1) Being a Foreign National, Mr. Michael Thomas Neeb (Independent Director) doesnt have PAN.



Annexure 1

II. Composition of Committees
Disclosure of notes on composition of committees explanatory



Audit Committee Details
Whether the Audit Committee has a Regular Chairperson Yes
Sr DIN Number Name of Committee members Category 1 of directors Category 2 of directors Date of Appointment Date of Cessation Remarks
1 00012920 Mahendra Gumanmalji Lodha Non-Executive - Independent Director Chairperson 21-Jun-2019
2 08333492 Amrita Gangotra Non-Executive - Independent Director Member 29-Oct-2023
3 08522685 Michael Thomas Neeb Non-Executive - Independent Director Member 11-Feb-2021
4 10738300 Mehta Pranav Chandrakant Non-Executive - Independent Director Member 26-Sep-2024



Nomination and remuneration committee
Whether the Nomination and remuneration committee has a Regular Chairperson Yes
Sr DIN Number Name of Committee members Category 1 of directors Category 2 of directors Date of Appointment Date of Cessation Remarks
1 00245099 Pranav Chirayu Amin Non-Executive - Independent Director Chairperson 30-Sep-2022
2 00012920 Mahendra Gumanmalji Lodha Non-Executive - Independent Director Member 29-Oct-2023
3 08522685 Michael Thomas Neeb Non-Executive - Independent Director Member 26-Sep-2024



Stakeholders Relationship Committee
Whether the Stakeholders Relationship Committee has a Regular Chairperson Yes
Sr DIN Number Name of Committee members Category 1 of directors Category 2 of directors Date of Appointment Date of Cessation Remarks
1 00245099 Pranav Chirayu Amin Non-Executive - Independent Director Chairperson 30-Sep-2022
2 00203597 Abhay Soi Executive Director Member 19-Jun-2020
3 00012920 Mahendra Gumanmalji Lodha Non-Executive - Independent Director Member 30-Sep-2022



Risk Management Committee
Whether the Risk Management Committee has a Regular Chairperson Yes
Sr DIN Number Name of Committee members Category 1 of directors Category 2 of directors Date of Appointment Date of Cessation Remarks
1 00053563 Narayan Keelveedhi Seshadri Non-Executive - Non Independent Director Chairperson 29-Oct-2023
2 00203597 Abhay Soi Executive Director Member 29-Oct-2023
3 08333492 Amrita Gangotra Non-Executive - Independent Director Member 29-Oct-2023
4 00245099 Pranav Chirayu Amin Non-Executive - Independent Director Member 26-Sep-2024
5 99999999 Mradul Kaushik Sr. Director–Operations & Planning & COO-Cluster 1 Member 29-Oct-2023
6 99999999 Vandana Ramesh Pakle Sr. Director – Corporate Affairs Member 29-Oct-2023
7 99999999 Yogesh Kumar Sareen Sr. Director – Chief Financial Officer Member 29-Oct-2023



Annexure 1
III. Meeting of Board of Directors
Disclosure of notes on meeting of board of directors explanatory
Sr Date(s) of meeting (Enter dates of Previous quarter and Current quarter in chronological order) Maximum gap between any two consecutive (in number of days) Notes for not providing Date Whether requirement of Quorum met (Yes/No) Total Number of Directors as on date of the meeting Number of Directors present* (All directors including Independent Director) No. of Independent Directors attending the meeting*
1 01-Aug-2024 Yes 8 8 5
2 13-Sep-2024 42 Yes 9 8 5
3 05-Nov-2024 52 Yes 8 8 5



Annexure 1
IV. Meeting of Committees
Disclosure of notes on meeting of committees explanatory
Sr Name of Committee Date(s) of meeting (Enter dates of Previous quarter and Current quarter in chronological order) Maximum gap between any two consecutive (in number of days) Name of other committee Reson for not providing date Whether requirement of Quorum met (Yes/No) Total Number of Directors in the Committee as on date of the meeting Number of Directors Present (All Directors including Independent Director) No. of Independent Directors attending the meeting* No. of members attending the meeting (other than Board of Directors)
1 Audit Committee 01-Aug-2024 Yes 4 4 4 0
2 Audit Committee 15-Oct-2024 74 Yes 4 4 4 0
3 Audit Committee 05-Nov-2024 20 Yes 4 4 4 0
4 Nomination and remuneration committee 31-Jul-2024 Yes 3 3 3 0
5 Nomination and remuneration committee 13-Sep-2024 43 Yes 3 2 2 0
6 Nomination and remuneration committee 05-Nov-2024 52 Yes 3 3 3 0
7 Stakeholders Relationship Committee 31-Jul-2024 Yes 3 3 2 0
8 Risk Management Committee 15-Oct-2024 75 Yes 4 4 2 3



Annexure 1
VI. Affirmations
Sr Subject Compliance status (Yes/No)
1 The composition of Board of Directors is in terms of SEBI (Listing obligations and disclosure requirements) Regulations, 2015 Yes
2 The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015 a. Audit Committee Yes
3 The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. b. Nomination & remuneration committee Yes
4 The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. c. Stakeholders relationship committee Yes
5 The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. d. Risk management committee (applicable to the top 1000 listed entities) Yes
6 The committee members have been made aware of their powers, role and responsibilities as specified in SEBI (Listing obligations and disclosure requirements) Regulations, 2015. Yes
7 The meetings of the board of directors and the above committees have been conducted in the manner as specified in SEBI (Listing obligations and disclosure requirements) Regulations, 2015 Yes
8 This report and/or the report submitted in the previous quarter has been placed before Board of Directors. Yes
9 Any comments/observations/advice of Board of Directors may be mentioned here: Integrated Filing - Governance Report of this quarter will be placed at the upcoming meeting of the Board of Directors in terms of applicable regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.



Annexure 1
Sr Subject Compliance status
1 Name of signatory Dhiraj Aroraa
2 Designation Company Secretary and Compliance Officer



Details of Cyber security incidence
Whether as per Regulation 27(2)(ba) of SEBI (LODR) Regulations, 2015 there has been cyber security incidents or breaches or loss of data or documents during the quarter No
Other details of cyber security incidence or breaches or loss of data event
Number of cyber security incidence or breaches or loss of data event occurred during the quarter
Sr Date of the event Brief details of the event



Signatory Details
Name of signatory Dhiraj Aroraa
Designation of person Company Secretary and Compliance Officer
Place Gurugram
Date 13-Feb-2025


Investor Grievance Details
No. of investor complaints pending at the beginning of Quarter 0
No. of investor complaints received during the Quarter 0
No. of investor complaints disposed off during the Quarter 0
No. of investor complaints those remaining unresolved at the end of the Quarter 0


Disclosure of Acquisition of Shares or Voting Rights in Unlisted Companies-
The details of acquisition of shares or voting rights in unlisted companies during the quarter in terms of sub-para 1 of para A of Part A of Schedule III are given below
Any Other Information for Disclosure of Acquisition of Shares or Voting Rights in Unlisted Companies The Company on October 4, 2024, acquired 63.65% equity stake in Jaypee Healthcare Limited. Further, on November 11, 2024, completed the acquisition of the remaining 36.35% equity stake. The aforesaid transaction was disclosed to the Stock Exchanges as per the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Sr. No. Name of the unlisted company in which shares or voting rights have been acquired Date of acquisition Aggregate holding (% shares or voting rights) as at the end of the previous quarter % shares or voting rights acquired during the quarter Aggregate holding (% shares or voting rights) as at the end of the quarter
1 Jaypee Healthcare Limited 11-Nov-2024 0 100 100


Disclosure of Imposition of Fine or Penalty
The details of imposition of fine or penalty during the quarter in terms of sub-para 20 of para A of Part A of Schedule III are given below:
Any Other Information for Disclosure of Imposition of Fine or Penalty
Sr. No. Name of the authority Nature and details of the action(s) taken or order(s) passed Date of receipt of direction or order, including any ad interim or interim orders, or any other communication from the authority Details of the violation(s)/ contravention(s) committed or alleged to be committed Impact on financial, operation or other activities of the listed entity, quantifiable in monetary terms to the extent possible


Disclosure of Updates to Ongoing Tax Litigations or Disputes
The updates on tax litigations or disputes in terms of sub-para 8 of para B of Part A of Schedule III read with corresponding provisions of Annexure 18 of the Master Circular are given below:

Any Other Information for Disclosure of Updates to Ongoing Tax Litigations or Disputes
Sr. No. Name of the opposing party Date of initiation of the litigation / dispute Status of the litigation / dispute as per last disclosure Current status of the litigation / dispute